- Nachrichtendetail
-
08.05.2024 14:04:17 - dpa-AFX: *ABBVIE : HEALTH CANADA APPROVES QULIPTA FOR PREVENTIVE TREATMENT OF CHRONIC MIGRAINE IN ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Xetra | 144,680 | 31.05.24 10:12:15 | +0,880 | +0,61% | 143,880 | 144,780 | 144,480 | 143,800 |
